Leverkusen, Germany

Helmut Kramer

This inventor holds 1 USPTO granted patent. Top assignee: Bayer Aktiengesellschaft. Active years: 1978.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 258(Granted Patents)


Company Filing History:


Years Active: 1978

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Helmut Kramer: Innovator in Enteral Pharmaceutical Compositions

Introduction

Helmut Kramer, a distinguished inventor based in Leverkusen, Germany, has made significant contributions to the field of pharmaceuticals. He is known for his innovative approaches to developing drug formulations that enhance safety and efficacy.

Latest Patents

Kramer's notable patent, titled "Enteral Pharmaceutical Compositions," focuses on formulations that contain medicinal agents with potential for parenteral abuse. His invention cleverly incorporates a sufficient amount of a nontoxic, water gelable material, rendering these compositions resistant to aqueous extraction. This innovation is critical in preventing attempts to extract the medicinal agent for illicit use, as the material forms a gel in the presence of water, leaving no filterable liquid.

Career Highlights

Throughout his career, Helmut Kramer has been associated with Bayer Aktiengesellschaft, a leading global company in the pharmaceutical industry. His work in developing safer pharmaceutical compositions has not only advanced the field but also established him as a prominent figure among his peers.

Collaborations

Kramer has collaborated with esteemed colleagues, including Friedrich Hoffmeister and Rudolf Hiltmann, contributing to the collective expertise and innovation within Bayer. These collaborations have resulted in further advancements in pharmaceutical technology, enhancing the safety profiles of various medicinal preparations.

Conclusion

Helmut Kramer's contributions reflect a deep commitment to pharmaceutical innovation and public safety. His patent on enteral pharmaceutical compositions demonstrates the potential of research and collaboration in creating safer medication alternatives. Through his work at Bayer Aktiengesellschaft, Kramer continues to inspire future innovations in the pharmaceutical sector.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…